We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Jagannath - Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in High-Risk and/or Stage 2-3 Relapsed and/or Refractory Multiple Myeloma: A Retrospective Subset Analysis of the Phase 2 Study
Sundar Jagannath, MD
Mount Sinai Medical Center
New York, New York, USA
12.06.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles